Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)

This grant provides funding for researchers to conduct preclinical studies on the effects of radionuclide-based cancer therapies, aiming to improve treatment strategies and outcomes for cancer patients.

$500,000

Closed

Nationwide

Grant Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types of radiation used in radionuclide-based therapeutics (e.g., radiopharmaceutical therapy) on normal tissue, tumor cells and the tumor microenvironment.

Funding Details

Award Range

Not specified - $500,000

Total Program Funding

Not specified

Number of Awards

Not specified

Matching Requirement

Eligibility

Eligible Applicants

State governments

County governments

City or township governments

Special district governments

Independent school districts

Additional Requirements

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Geographic Eligibility

All

Key Dates

Application Opens

March 18, 2022

Application Closes

November 17, 2024

Contact Information

Grantor

NIH OER Webmaster

OERWebmaster03@od.nih.gov

Subscribe to view contact details

Newsletter Required